Oral Multiple-dose Study in Patients With Major Depressive Disorder
NCT01924520
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
FK949E
Sponsor
Astellas Pharma Inc